Unleashing the Power of RNA to Treat Depression

Circular Genomics is a biotechnology and genomics company with a vision to use circular RNAs as novel and improved biomarkers for the diagnosis and better treatment of psychiatric and neurological diseases

Depression is a Global Health Crisis

Almost one third of the US population currently experience symptoms of depression

First-line treatments are only 40% effective

It can take over a year to find an appropriate therapeutic and dose

What We Do

Fast. Reliable. Efficient.

Our circRNA Depression Assay will use stable and reliable biomarkers to help physicians provide personalized precision healthcare to individuals with depression

Chart demonstrating that US Depression Rates increased by 3 times during the Covid-19 pandemic.

The Need has Never Been Greater

Depression rates are 3-times higher than the beginning of the Covid-19 pandemic

- US Census Bureau, Household Survey, 2020-2021

Our Story

Get in Touch

We’re happy to hear from you! Contact us for more information on our research or to meet with a member of our team.

5901 Indian School Rd NE, Albuquerque, NM

info@circulargenomics.com